Treffer 1 - 6 von 6 für Suche 'Mohhamed, Hisham', Suchdauer: 0,36s Treffer weiter einschränken
  1. 1
    Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer

    Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer von Giannoudis, Athina, Malki, Mohammed Imad, Rudraraju, Bharath, Mohhamed, Hisham, Menon, Suraj, Liloglou, Triantafillos, Ali, Simak, Carroll, Jason S., Palmieri, Carlo

    Veröffentlicht in Breast cancer research : BCR

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer

    Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer von Giannoudis, Athina, Malki, Mohammed Imad, Rudraraju, Bharath, Mohhamed, Hisham, Menon, Suraj, Liloglou, Triantafillos, Ali, Simak, Carroll, Jason S, Palmieri, Carlo

    Volltext bestellen
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer

    Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer von Giannoudis, Athina, Malki, Mohammed Imad, Rudraraju, Bharath, Mohhamed, Hisham, Menon, Suraj, Liloglou, Triantafillos, Ali, Simak, Carroll, Jason S, Palmieri, Carlo

    Volltext bestellen
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Additional file 4 of Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer

    Additional file 4 of Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer von Giannoudis, Athina, Malki, Mohammed Imad, Bharath Rudraraju, Mohhamed, Hisham, Menon, Suraj, Triantafillos Liloglou, Simak Ali, Carroll, Jason S., Palmieri, Carlo

    Volltext bestellen
    Dataset

    Zu den Favoriten
    Gespeichert in:
  5. 5
    Additional file 3 of Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer

    Additional file 3 of Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer von Giannoudis, Athina, Malki, Mohammed Imad, Bharath Rudraraju, Mohhamed, Hisham, Menon, Suraj, Triantafillos Liloglou, Simak Ali, Carroll, Jason S., Palmieri, Carlo

    Volltext bestellen
    Dataset

    Zu den Favoriten
    Gespeichert in:
  6. 6
    Additional file 5 of Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer

    Additional file 5 of Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer von Giannoudis, Athina, Malki, Mohammed Imad, Bharath Rudraraju, Mohhamed, Hisham, Menon, Suraj, Triantafillos Liloglou, Simak Ali, Carroll, Jason S., Palmieri, Carlo

    Volltext bestellen
    Dataset

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: